Most DMD preclinical studies have been carried out in the mdx mouse that carries a nonsense point mutation in DMD exon 23 [80], which is only one out of the thousands of possible variations in this gene present in DMD patients. This evidence concerns the gene DMD and Duchenne muscular dystrophy.